Rasagiline Mesylate
Closed Pre-Solicitation Posted
- Solicitation number
- SPE2D220R0070
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency intends to issue a solicitation seeking a national requirements contract to supply Rasagiline Mesylate 0.5MG and 1MG tablets in bottle counts of 30. The contract will have a one-year base period and four one-year options utilizing fixed pricing. Annual usage estimates and eligible government customers will be included in the solicitation schedule. Interested offerors should monitor the DLA Bid Board System and SAM.gov where the full solicitation will be posted with a closing date of October 1, 2020. Offerors should contact the specified representatives with any questions.
There is no set-aside designation for this procurement. The NAICS code is 325412 with a PSC code of 6505. The incumbent contract is SPE2D2-21-D-0133 which was recently modified to exercise the first option year. The estimated annual contract value is undisclosed but will supply requirements to the Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs on an as-needed basis over the five-year period.
Notice text
2 versions
Update #2 · Latest ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rasagiline Mesylate 0.5MG and 1MG Tablets in bottle counts of 30. Procurement details follow.
This will be an unrestricted and fully competitive acquisition. The contract will be a fixed price, requirements type contract with a one-year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Beta Sam.Gov at https://beta.sam.gov. Interested parties should contact Denise Taubman (215)737-8677/Denise.Taubman@dla.mil or Christopher Newman (215)737-2905/Christopher.Newman@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is July 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
CONTRACT AS RESULT OF SOLICITATION: SPE2D2-21-D-0133 (SPE2D221D0133)
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rasagiline Mesylate 0.5MG and 1MG Tablets in bottle counts of 30. Procurement details follow.
This will be an unrestricted and fully competitive acquisition. The contract will be a fixed price, requirements type contract with a one-year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Beta Sam.Gov at https://beta.sam.gov. Interested parties should contact Denise Taubman (215)737-8677/Denise.Taubman@dla.mil or Christopher Newman (215)737-2905/Christopher.Newman@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is July 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Attachments
| File | Type | Posted |
|---|---|---|
| SPE2D221D0133 P00002 (executed).pdf | ||
| SPE2D221D0133-P00001.PDF | ||
| signed Rasagiline SPE2D221D0133.pdf | ||
| SPE2D220R00700001.pdf | ||
| Rasagiline Mesylate Solicitation.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity